This second pandemic year affirmed the drug industry's strength in tackling public health crises. Headlines in 2021 were dominated by the arrival of COVID-19 vaccines and, recently, antiviral treatments, but pharmaceutical and biotech companies also continued to work on new technologies that could transform care for people with other diseases.
